Antimicrobial activity of ibuprofen: New perspectives on an "old" non-antibiotic drug

European Journal of Pharmaceutical Sciences

Volumn 71, Issue , 2015, Pages 93-98

  Obad, Jelena ^a   Šušković, Jagoda ^b   Kos, Blaženka ^b  

^a Department of Analytical Laboratories Belupo Inc ^*  (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Disk diffusion; European Pharmacopoeia; Ibuprofen; Method suitability; Microbiological purity; Non antibiotic

Indexed keywords

CITRIC ACID; IBUPROFEN; IBUPROFEN LYSINE; ANTIINFECTIVE AGENT; LYSINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS BRASILIENSIS; BACILLUS SUBTILIS; BACTERIUM COLONY; CANDIDA ALBICANS; CONTROLLED STUDY; DISK DIFFUSION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG INDUSTRY; ESCHERICHIA COLI; INOCULATION; LAMINAR AIRFLOW; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PATIENT INFORMATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; ANALOGS AND DERIVATIVES; BACTERIUM; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPERGILLUS; BACTERIA; CANDIDA ALBICANS; IBUPROFEN; LYSINE;

EID: 84924087708     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.02.011     Document Type: Article

References (33)

1. A.A. Al-Janabi In vitro antibacterial activity of ibuprofen and acetaminophen J. Global Infect. Dis. 2 2010 105 108
2. Antimicrobial susceptibility testing, EUCAST disk diffusion method (version 3.0), European Committee on Antimicrobial Susceptibility Testing (EUCAST), European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland, 2013. < http://www.eucast.org > (accessed 1.06.14).
3. Council of Europe, 2010. Microbiological examination of non-sterile products: Microbial enumeration tests (chapter 2.6.12.). In: European Pharmacopoeia, Council of Europe, Strasbourg, France, vol. 7.0, pp. 163-167.
4. Council of Europe, 2010. Microbiological examination of non-sterile products: Test for specified microorganisms (chapter 2.6.13.). In: European Pharmacopoeia, Council of Europe, Strasbourg, France, vol. 7.0, pp. 167-171.
5. Council of Europe, 2010. Microbiological quality of non-sterile pharmaceutical preparations and substances for pharmaceutical use (chapter 5.1.4.). In: European Pharmacopoeia, Council of Europe, Strasbourg, France, vol. 7.0, pp. 507.
6. Council of Europe, 2010. Ibuprofen (monograph). In: European Pharmacopoeia, Council of Europe, Strasbourg, France, vol. 7.0, pp. 2225-2227.
7. N.M. Davies Clinical pharmacokinetics of ibuprofen. The first 30 years Clin. Pharmacokinet. 34 1998 101 154
8. G. Del Prado, V. Ruiz, P. Naves, V. Rodriguez-Cerrato, F. Soriano, and M.C. Ponte Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-L-cysteine, amoxicillin, erythromycin and levofloxacin Diagn. Microbiol. Infect. Dis. 67 2010 311 318
9. Dimethyl Sulfoxide (DMSO) Solubility Data, Gaylord Chemical Company L.L.C.; Slidell, LA, USA. < http://www.gaylordchemical.com > (accessed 17.06.14).
10. Dollery, C.; 1999. Ibuprofen. In: Therapeutic drugs, Churchill Livingstone, London, UK, pp. 11-13.
11. K.T. Elvers, and S.J. Wright Antibacterial activity of the anti-inflammatory compound ibuprofen Lett. Appl. Microbiol. 20 1995 82 84
12. A. Espinel-Ingroff Multicentre evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin J. Clin. Microbiol. 45 2007 1811 1820
13. J.L. Finquelievich, C. Iovannitti, F. Landaburu, G. Raffin, N. SanJuan, M.R. Elias-Costa, and R. Negroni Diminution of antifungal activity of fluconazole associated with ibuprofen and piroxicam in experimental histoplasmosis of hamsters (Mesocricetus auratus) Revista Iberoamericana de Micologia 19 2002 40 43 (in Spanish)
14. P. Hili, C.S. Evans, and R.G. Veness Antimicrobial action of essential oils: the effect of dimethylsulphoxide on the activity of cinnamon oil Lett. Appl. Microbiol. 24 1997 269 275
15. V.V. Hynninen, K.T. Olkkola, K. Leino, S. Lundgren, P.J. Neuvonen, and A. Rane Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of S-(+)- and R-(-)-Ibuprofen Antimicrob. Agents Chemother. 50 2006 1967 1972
16. A. Jiménez-Serna, and H. Hernández-Sánchez Effect of different antibiotics and non-steroidal anti-inflammatory drugs on the growth of Lactobacillus casei Shirota Curr. Microbiol. 62 2011 1028 1033
17. O. Karabay, E. Kocoglu, N. Ince, T. Sahan, and D. Ozdemir In vitro activity of sodium benzoate against clinically relevant Enterococcus faecalis and Enterococcus faecium isolates J. Microbiol. 44 2006 129 131
18. H. Kruszewska, T. Zareba, and S. Tyski Examination of antimicrobial activity of selected non-antibiotic drugs Acta Pol. Pharm. 61 2004 18 21
19. H. Kruszewska, T. Zareba, and S. Tyski Examination of antimicrobial activity of selected non-antibiotic medicinal preparations Acta Pol. Pharm. 69 2012 1368 1371
20. G.L. Mandell, and E.J. Coleman Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorhonuclear leukocytes J. Infect. Dis. 185 2002 1314 1319
21. M. Martins, S.G. Dastidar, S. Fanning, J.E. Kristiansen, J. Molnar, and J.M. Pages Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities Int. J. Antimicrob. Agents 31 2008 198 208
22. K. Mazumdar, Kumar K. Asok, and N.K. Dutta Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future Int. J. Antimicrob. Agents 36 2010 295 302
23. M. Milani, and P. Iacobelli Vaginal use of Ibuprofen isobutanolammonium (Ginenorm): efficacy, tolerability, and pharmacokinetic data: a review of available data ISRN Obstet. Gynecol. 2012 2012
24. R.A. Moore, S. Derry, S. Straube, J. Ireson-Paine, and P.J. Wiffen Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain Pain 155 2014 14 21
25. Mueller-Hinton Agar - technical info, Merck KGaA, Darmstadt, Germany. < http://www.emdmillipore.com > (accessed 22.12.14).
26. B.S. Nagoba, S.R. Deshmukh, B.J. Wadher, L. Mahabaleshwar, R.C. Gandhi, and P.B. Kulkarni Treatment of superficial pseudomonal infections with citric acid: an effective and economical approach J. Hosp. Infect. 40 1998 155 157
27. D. Perlman Lysine and lysine analog potentiation of antibiotic and antimicrobial activity J. Antibiot. 28 1975 997 999
28. C. Pina-Vaz, F. Sansonetty, A.G. Rodrigues, J. Martinez-de-Oliveira, A.F. Fonseca, and P.A. Mårdh Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species J. Med. Microbiol. 49 2000 831 840
29. C. Pina-Vaz, A.G. Rodrigues, S. Costa-de-Oliveira, E. Ricardo, and P.A. Mårdh Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry J. Antimicrob. Chemother. 56 2005 678 685
30. PubChem Substance Database, National Centre for Biotechnology Information, Bethesda, MD, USA. < http://pubchem.ncbi.nlm.nih.gov > (accessed 23.12.2014).
31. A.M. Rediske, B.L. Roeder, M.K. Brown, J.L. Nelson, R.L. Robison, and D.O. Draper Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model Antimicrob. Agents Chemother. 43 1999 1211 1214
32. H. Shirin, S.F. Moss, S. Kancherla, K. Kancherla, P.R. Holt, I.B. Weinstein, and E.M. Sordillo Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori J. Gastroenterol. Hepatol. 21 2006 1388 1393
33. V.N. Tariq, E.M. Scott, and N.E. McCain Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro Antimicrob. Agents Chemother. 39 1995 2615 2619